Description
The Critical Medicines Alliance (CMA) is a consultative body uniting stakeholders from EU Member States, key industries, civil society, and the scientific community. Its goal is to identify priorities and propose solutions to strengthen the supply of critical medicines in the EU, effectively preventing and addressing shortages.
The Critical Medicines Alliance Forum, open to all Alliance members, serves as a platform for regular consultation on key milestones, activities and initiatives of the Alliance. Members actively contribute to discussions on the Alliance's progress, while addressing shortages of critical medicines by providing insights and feedback.
Membership
List of member organisations based on applications submitted before 3 June 2024
The Alliance is open to new members at all stages of its operation. The specific membership criteria are set out in the Alliance Terms of Reference. To become a member, an organisation must sign the Alliance Declaration, signifying alignment with the Alliance's vision and a commitment to actively contribute to its operational efforts.
Meetings
Inaugural meeting of the Forum of the Critical Medicines Alliance
Thursday 25 April 2024
Brussels
For members – Log in
This space is designed exclusively for Critical Medicines Alliance (CMA) Forum members, to support engagement and collaboration through the following efforts.
-
View documents: Access and review all relevant documents and materials pertaining to the Alliance’s initiatives and activities.
-
Follow discussions: Stay informed and participate in ongoing discussions, contributing your insights and perspectives.
-
Vote and provide input: Engage in the decision-making process by casting your vote and providing input on documents as they are adopted by the Alliance.
We encourage you to explore the workspace and take full advantage of the resources and opportunities available to you as a valued member of the Critical Medicines Alliance.